Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
Neutralizing antibody (NAb) titer is a key biomarker of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but point-of-care methods for assessing NAb titer are not widely available. Here, we present a lateral flow assay that captures SARS-CoV-2 receptor-bindi...
Main Authors: | Connelly, Guinevere G, Kirkland, Orville O, Bohannon, Seven, Lim, Daniel C, Wilson, Robert M, Richards, Edward J, Tay, Dousabel M, Jee, Hyuk, Hellinger, Riley D, Hoang, Ngoc K, Hao, Liang, Chhabra, Arnav, Martin-Alonso, Carmen, Tan, Edward KW, Koehler, Angela N, Yaffe, Michael B, London, Wendy B, Lee, Pui Y, Krammer, Florian, Bohannon, Robert C, Bhatia, Sangeeta N, Sikes, Hadley D, Li, Hojun |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2023
|
Online Access: | https://hdl.handle.net/1721.1/147025 |
Similar Items
-
Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
by: Rosana Wing-Shan Poon, et al.
Published: (2021-11-01) -
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5
by: Zhantong Wang, et al.
Published: (2023-12-01) -
Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies
by: Hasmik Manukyan, et al.
Published: (2020-03-01) -
The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
by: William D. Tolbert, et al.
Published: (2023-06-01) -
Application and Validation of SARS-CoV-2 RBD Neutralizing ELISA Assay
by: Z. S Mousa, et al.
Published: (2022-02-01)